Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
GU tumors
Jun 28, 2024, 12:11 |
Blog
Carmen Uscatu: When do we know that we are on the right track?
Carmen Uscatu, President at Give Life, shared a post on LinkedIn: . “When do we…
Jun 28, 2024, 11:48 |
Blog
Patrick Hwu: Let us talk remote work on National Work From Home Day
Patrick Hwu shared a post LinkedIn: “Let us talk remote work on National Work From…
Jun 28, 2024, 11:27 |
Societies
12 Posts You Should Not Miss From Day 2 of ESMOGI24!
ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…
Jun 28, 2024, 06:45 |
Positive
Patrick Hwu: Moffitt Cancer Center is at the forefront of cancer discovery
Patrick Hwu shared on X: "Bioengineering is vital to making strides in cancer discovery, and…
Jun 28, 2024, 05:16 |
Blog
'Mega Lungs' helped Luis E. Raez and Gelenis Domingo shed light on the urgency of raising awareness of lung cancer
Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post on LinkedIn: "Memorial…
Jun 27, 2024, 08:45 |
Blog
Some papers to read today suggested by Wafik S. El-Deiry
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, shared…
Jun 26, 2024, 08:30 |
Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
Jun 25, 2024, 16:01 |
Insight
Paolo Tarantino: Phase 1 trial of the HER2 topo1 ADC SHR-A1811 out in Journal of Clinical Oncology
Paolo Tarantino shared on X: . "Phase 1 trial of the HER2 topo1 ADC SHR-A1811…
Jun 25, 2024, 12:52 |
Blog
Tali Lev: Excited to attend the Metastasis Research Society 20th Biennial meeting
Tali Lev, Senior Editor at Cancer Discovery, made the following post on X: . "Hi from…
Jun 25, 2024, 03:54 |
Insight
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System
Maria Natalia Gandur Quiroga shared on LinkedIn: "Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring…
44
45
46
47
48
All:
741
Posts:
451 - 460
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube